SCOPUS 정보 검색 플랫폼

Journal of Clinical Gastroenterology

Volumn 35, Issue 2, 2002, Pages 149-150

Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab: A case series

(3) Kane, Sunanda a Stone, Lee Jayson a Ehrenpreis, Eli a

a UNIVERSITY OF CHICAGO (United States)

Author keywords

Crohn's disease; Infliximab; Thalidomide; Therapy

Indexed keywords

INFLIXIMAB; THALIDOMIDE; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; DELAYED HYPERSENSITIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SEDATION; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; FOLLOW UP; MIDDLE AGED; SALVAGE THERAPY; TIME;

ADULT; ANTIBODIES, MONOCLONAL; CASE REPORT; CROHN DISEASE; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW-UP STUDIES; HUMAN; HYPERSENSITIVITY, DELAYED; MALE; MIDDLE AGE; SALVAGE THERAPY; SUPPORT, NON-U.S. GOV'T; THALIDOMIDE; TIME FACTORS; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0036020424 PISSN: 01920790 EISSN: None Source Type: Journal
DOI: 10.1097/00004836-200208000-00006 Document Type: Article

Times cited : (33)

References (15)

1
- 0030954732
- A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
- Crohn's Disease cA2 Study Group
- (1997) N Engl J Med , vol.337 , pp. 1029-1035
- Targan, S.R.¹ Hanauer, S.B.² Van Deventer, S.J.³

2
- 0033529049
- Infliximab for the treatment of fistulas in patients with Crohn's disease
- (1999) N Engl J Med , vol.340 , pp. 1398-1405
- Present, D.H.¹ Rutgeerts, P.J.² Targan, S.R.³

3
- 0000200979
- Delayed hypersensitivity to infliximab (Remicade): Re-infusion after 2-4 year interval without treatment
- (1999) Gastroenterology , vol.116
- Hanauer, S.B.¹ Rutgeerts, P.J.² D'Haens, G.³

4
- 0026080801
- Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes
- (1991) J Exp Med , vol.173 , pp. 699-703
- Sampaio, E.P.¹ Sarno, E.N.² Galilly, R.³

5
- 0028216334
- Thalidomide is an inhibitor of angiogenesis
- (1994) Proc Natl Acad Sci , vol.91 , pp. 4082-4085
- D'Amato, R.J.¹ Loughnan, M.S.² Flynn, E.³

6
- 0030859308
- Thalidomide in oral Crohn's disease refractory to conventional medical treatment
- (1997) J Pediatr Gastroenterol Nutr , vol.25 , pp. 250-251
- Odeka, E.B.¹ Miller, V.²

7
- 0032975429
- Thalidomide for the treatment of oral ulcers in Crohn's disease
- (1999) J Pediatr Gastroenterol Nutr , vol.28 , pp. 214-216
- Weinstein, T.A.¹ Sciubba, J.J.² Levine, J.³

8
- 0035050026
- Treatment of severe esophageal Crohn's disease with thalidomide
- (2001) Am J Gastroenterol , vol.96 , pp. 1305-1306
- Ginsburg, P.M.¹ Hanan, I.² Ehrenpreis, E.D.³

9
- 0031583764
- Thalidomide in Crohn's disease
- (1997) Lancet , vol.350 , pp. 1445-1446
- Wettstein, A.R.¹ Meagher, A.P.²

10
- 0032714591
- Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial
- (1999) Gastroenterology , vol.117 , pp. 1-8
- Ehrenpreis, E.D.¹ Kane, S.V.² Cohen, L.B.³

11
- 0032714405
- An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
- (1999) Gastroenterology , vol.117 , pp. 1278-1287
- Vasiliauskas, E.A.¹ Kam, L.Y.² Abreu-Martin, M.T.³

12
- 0034572297
- Thalidomide in solid tumors: The London experience
- (2000) Oncology (Huntingt) , vol.14 , Issue.SUPPL. 13 , pp. 17-20
- Eisen, T.G.¹

13
- 0034189370
- Thalidomide: A remarkable comeback
- (2000) Expert Opin Pharmacother , vol.1 , pp. 849-863
- Jacobson, J.M.¹

14
- 0035162074
- Thalidomide
- (2001) Dermatol Clin , vol.19 , pp. 87-103
- Radomsky, C.L.¹ Levine, N.²

15
- 0035071241
- Efficacy of long-term treatment with thalidomide in children and young adults with Crohn's disease: Preliminary results
- (2001) J Pediatr Gastroenterol Nutr , vol.32 , pp. 178-181
- Facchini, S.¹ Candusso, M.² Martelossi, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.